Be part of the knowledge.™

Ophthalmology

62

LikeLikedUnlike

31-45 of 77

Early Fluid Resolution – A Key to Long-Term Success
MinuteCE®
Early Fluid Resolution – A Key to Long-Term Success
- Roger A. Goldberg, MD, MBA
- Ehsan Rahimy, MD
1.00 program credits
MinuteCE®
Biomarking the Difference: How Second-Generation Therapies are Changing the Game
- Justis P. Ehlers, MD, FASRS
- Roger A. Goldberg, MD, MBA
- Jennifer, I. Lim, MD, FASRS, FARVO
- Ehsan Rahimy, MD
1.00 credits 10 episodes
Real-World Adaptation of Trial Protocols
MinuteCE®
Real-World Adaptation of Trial Protocols
- Roger A. Goldberg, MD, MBA
- Ehsan Rahimy, MD
1.00 program credits
Beyond Durability - What Biomarkers Reveal About Disease Control
MinuteCE®
Beyond Durability - What Biomarkers Reveal About Disease Control
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credits
The Durability Dilemma
MinuteCE®
The Durability Dilemma
- Roger A. Goldberg, MD, MBA
- Ehsan Rahimy, MD
1.00 program credits
Signs of Progress: PED as a Predictor of Disease and Outcomes
MinuteCE®
Signs of Progress: PED as a Predictor of Disease and Outcomes
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credits
advertisement
New Strategies for Individualizing Treatment in DME
CME/CE
New Strategies for Individualizing Treatment in DME
- Luis A. Gonzalez, MD, MPH
- Jeremiah Brown Jr., MD, MS, FASRS
0.25 credits
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
CME/CE
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
- Luis A. Gonzalez, MD, MPH
- Jeremiah Brown Jr., MD, MS, FASRS
0.25 credits
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
CME/CE Broadcast Replay
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
- Kathleen N. Moore, MD, MS, FASCO
- Aaron Samuel Gold, OD, FAAO
- Carlo J. Pelino, OD, FAAO
1.00 credits
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
CME/CE
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
- Kathleen N. Moore, MD, MS, FASCO
- Kamran M. Riaz, MD
0.25 credits
Understanding Antibody-Drug Conjugates (ADCs)
CME/CE
Understanding Antibody-Drug Conjugates (ADCs)
- Aaron Samuel Gold, OD, FAAO
- Carlo J. Pelino, OD, FAAO
0.25 credits
Collaborative Care: Managing ADC-Related Ocular Toxicities
CME/CE
Collaborative Care: Managing ADC-Related Ocular Toxicities
- Kathleen N. Moore, MD, MS, FASCO
- Carlo J. Pelino, OD, FAAO
0.25 credits
advertisement
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
CME/CE
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
- Aaron Samuel Gold, OD, FAAO
- Timothy G. Murray, MD, MBA, FASRS
0.25 credits
KOL KNOCKOUT^TM OCULOPLASTICS EDITION 8 Cases of Tailored Treatment for Thyroid Eye Disease
CME/CE
KOL KNOCKOUT^TM OCULOPLASTICS EDITION 8 Cases of Tailored Treatment for Thyroid Eye Disease
- Andrew R. Harrison, MD
- Kian Eftekhari, MD
- Andrew G. Lee, MD
- Wendy W. Lee, MD
- Nicholas Robert Mahoney, MD
- Amina Malik, MD
- Prem S. Subramanian, MD, PhD
- Jeremiah Tao, MD, FACS
1.00 credits
MinuteCE®
What’s New in Glaucoma Therapy?
- Paul Petrakos, DO, MS
- Justin Schweitzer, OD, FAAO
- I. Paul Singh, MD
- Sarah H. Van Tassel, MD
1.00 credits 10 episodes

Program Chapters

Segment Chapters

Playlist:

Recommended